{
 "drug": "Sodium Bicarbonate Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "03/01/2017",
 "dayN": 3464,
 "cat": "Endocrinology/Metabolism",
 "companies": [
  "Exela Pharma Sciences, LLC",
  "Hospira, Inc., a Pfizer Company",
  "Amphastar Pharmaceuticals, Inc.",
  "Long Grove Pharmaceuticals LLC",
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [
  "Discontinuation of the manufacture of the drug",
  "Other",
  "Demand increase for the drug"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/24/2017",
   "package_ndc": "51754-5001-5",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "828-758-5474 ext. 154",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA211091"
    ],
    "brand_name": [
     "SODIUM BICARBONATE"
    ],
    "generic_name": [
     "SODIUM BICARBONATE"
    ],
    "manufacturer_name": [
     "Exela Pharma Sciences, LLC"
    ],
    "product_ndc": [
     "51754-5001",
     "51754-5011",
     "51754-5002",
     "51754-5012"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM BICARBONATE"
    ],
    "rxcui": [
     "807284",
     "1868486",
     "1923484",
     "2198792"
    ],
    "spl_id": [
     "4da0ba66-756d-4b4d-8018-81ca16578ef1"
    ],
    "spl_set_id": [
     "e9698a4f-1a95-4f28-a945-e8009d1d6dd4"
    ],
    "package_ndc": [
     "51754-5001-5",
     "51754-5001-4",
     "51754-5011-4",
     "51754-5002-5",
     "51754-5012-4"
    ],
    "unii": [
     "8MDF5V39QO"
    ]
   },
   "update_date": "07/22/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5001-5)",
   "company_name": "Exela Pharma Sciences, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/01/2017",
   "package_ndc": "0409-4900-14",
   "generic_name": "Sodium Bicarbonate Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Sodium%20Bicarbonate%20Injection&st=d",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 10 mEq/10 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-4900-14)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/01/2017",
   "package_ndc": "0409-5555-02",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "844-646-4398",
   "availability": "Limited Availability",
   "related_info": "Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "ANDA202981"
    ],
    "brand_name": [
     "SODIUM BICARBONATE"
    ],
    "generic_name": [
     "SODIUM BICARBONATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-5555"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM BICARBONATE"
    ],
    "rxcui": [
     "1868469"
    ],
    "spl_id": [
     "e3a44e63-8594-40b6-a3fa-d135b3149661",
     "bcb3a2dc-1a3f-4ac7-8ea2-426f0771c246"
    ],
    "spl_set_id": [
     "0c24b592-4bc8-456f-acac-9c9525844a06",
     "ea9f4498-0d43-4043-8dd1-f22537841c21"
    ],
    "package_ndc": [
     "0409-5555-11",
     "0409-5555-01",
     "0409-5555-12",
     "0409-5555-02"
    ],
    "unii": [
     "8MDF5V39QO"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "discontinued_date": "11/07/2025",
   "update_type": "New",
   "initial_posting_date": "11/07/2025",
   "package_ndc": "0409-6637-14",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA202494"
    ],
    "brand_name": [
     "SODIUM BICARBONATE"
    ],
    "generic_name": [
     "SODIUM BICARBONATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-6637",
     "0409-4916"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM BICARBONATE"
    ],
    "rxcui": [
     "727995",
     "792582"
    ],
    "spl_id": [
     "f79ec8cb-b6a3-4ffb-bccf-d39f59d65621"
    ],
    "spl_set_id": [
     "ea20a5eb-641e-48cd-bcfa-74c04c45dfda"
    ],
    "package_ndc": [
     "0409-4916-24",
     "0409-4916-14",
     "0409-6637-24",
     "0409-6637-14"
    ],
    "unii": [
     "8MDF5V39QO"
    ]
   },
   "update_date": "11/07/2025",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-6637-14)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/01/2017",
   "package_ndc": "0409-5534-14",
   "generic_name": "Sodium Bicarbonate Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Sodium%20Bicarbonate%20Injection&st=d",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 5 mEq/10 mL (4.2%, 0.5 mEq/mL) Syringes (NDC 0409-5534-14)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/01/2017",
   "package_ndc": "0409-6637-14",
   "generic_name": "Sodium Bicarbonate Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Sodium%20Bicarbonate%20Injection&st=d",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA202494"
    ],
    "brand_name": [
     "SODIUM BICARBONATE"
    ],
    "generic_name": [
     "SODIUM BICARBONATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-6637",
     "0409-4916"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM BICARBONATE"
    ],
    "rxcui": [
     "727995",
     "792582"
    ],
    "spl_id": [
     "f79ec8cb-b6a3-4ffb-bccf-d39f59d65621"
    ],
    "spl_set_id": [
     "ea20a5eb-641e-48cd-bcfa-74c04c45dfda"
    ],
    "package_ndc": [
     "0409-4916-24",
     "0409-4916-14",
     "0409-6637-24",
     "0409-6637-14"
    ],
    "unii": [
     "8MDF5V39QO"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-6637-14)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "discontinued_date": "11/07/2025",
   "update_type": "New",
   "initial_posting_date": "11/07/2025",
   "package_ndc": "0409-4916-14",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "11/07/2025",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 75 mg/1 mL (NDC 0409-4916-14)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/01/2017",
   "package_ndc": "0409-5555-01",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery and Estimated Recovery: April 2027; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "ANDA202981"
    ],
    "brand_name": [
     "SODIUM BICARBONATE"
    ],
    "generic_name": [
     "SODIUM BICARBONATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-5555"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM BICARBONATE"
    ],
    "rxcui": [
     "1868469"
    ],
    "spl_id": [
     "e3a44e63-8594-40b6-a3fa-d135b3149661",
     "bcb3a2dc-1a3f-4ac7-8ea2-426f0771c246"
    ],
    "spl_set_id": [
     "0c24b592-4bc8-456f-acac-9c9525844a06",
     "ea9f4498-0d43-4043-8dd1-f22537841c21"
    ],
    "package_ndc": [
     "0409-5555-11",
     "0409-5555-01",
     "0409-5555-12",
     "0409-5555-02"
    ],
    "unii": [
     "8MDF5V39QO"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/01/2017",
   "package_ndc": "76329-3352-1",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "800-423-4136",
   "availability": "Limited Availability",
   "related_info": "Available on allocation",
   "openfda": {
    "application_number": [
     "ANDA203449"
    ],
    "brand_name": [
     "SODIUM BICARBONATE"
    ],
    "generic_name": [
     "SODIUM BICARBONATE"
    ],
    "manufacturer_name": [
     "International Medication Systems, Limited"
    ],
    "product_ndc": [
     "76329-3352"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM BICARBONATE"
    ],
    "rxcui": [
     "792582"
    ],
    "spl_id": [
     "74a86dc7-0929-40d0-9661-9f9063a8fd7d"
    ],
    "spl_set_id": [
     "77698221-a01d-4568-a7bc-d3d4e982875d"
    ],
    "package_ndc": [
     "76329-3352-1"
    ],
    "unii": [
     "8MDF5V39QO"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)",
   "company_name": "Amphastar Pharmaceuticals, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/24/2017",
   "package_ndc": "51754-5012-4",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "828-758-5474 ext. 154",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA211091"
    ],
    "brand_name": [
     "SODIUM BICARBONATE"
    ],
    "generic_name": [
     "SODIUM BICARBONATE"
    ],
    "manufacturer_name": [
     "Exela Pharma Sciences, LLC"
    ],
    "product_ndc": [
     "51754-5012",
     "51754-5001",
     "51754-5011",
     "51754-5002"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM BICARBONATE"
    ],
    "rxcui": [
     "807284",
     "1868486",
     "1923484",
     "2198792"
    ],
    "spl_id": [
     "4da0ba66-756d-4b4d-8018-81ca16578ef1"
    ],
    "spl_set_id": [
     "e9698a4f-1a95-4f28-a945-e8009d1d6dd4"
    ],
    "package_ndc": [
     "51754-5001-5",
     "51754-5001-4",
     "51754-5011-4",
     "51754-5002-5",
     "51754-5012-4"
    ],
    "unii": [
     "8MDF5V39QO"
    ]
   },
   "update_date": "07/22/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4)",
   "company_name": "Exela Pharma Sciences, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/24/2017",
   "package_ndc": "51754-5011-4",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "828-758-5474 ext. 154",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA211091"
    ],
    "brand_name": [
     "SODIUM BICARBONATE"
    ],
    "generic_name": [
     "SODIUM BICARBONATE"
    ],
    "manufacturer_name": [
     "Exela Pharma Sciences, LLC"
    ],
    "product_ndc": [
     "51754-5011",
     "51754-5001",
     "51754-5002",
     "51754-5012"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM BICARBONATE"
    ],
    "rxcui": [
     "807284",
     "1868486",
     "1923484",
     "2198792"
    ],
    "spl_id": [
     "4da0ba66-756d-4b4d-8018-81ca16578ef1"
    ],
    "spl_set_id": [
     "e9698a4f-1a95-4f28-a945-e8009d1d6dd4"
    ],
    "package_ndc": [
     "51754-5001-5",
     "51754-5001-4",
     "51754-5011-4",
     "51754-5002-5",
     "51754-5012-4"
    ],
    "unii": [
     "8MDF5V39QO"
    ]
   },
   "update_date": "07/22/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4)",
   "company_name": "Exela Pharma Sciences, LLC",
   "status": "Current"
  },
  {
   "discontinued_date": "11/07/2025",
   "update_type": "New",
   "initial_posting_date": "11/07/2025",
   "package_ndc": "0409-4900-14",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "11/07/2025",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-4900-14)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/01/2017",
   "package_ndc": "0409-4916-14",
   "generic_name": "Sodium Bicarbonate Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Sodium%20Bicarbonate%20Injection&st=d",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 44.6 mEq/50 mL (7.5%, 0.9 mEq/mL) Syringes (NDC 0409-4916-14)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/01/2017",
   "package_ndc": "81298-7620-3",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "833-268-5559",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA216042"
    ],
    "brand_name": [
     "SODIUM BICARBONATE"
    ],
    "generic_name": [
     "SODIUM BICARBONATE INJECTION,"
    ],
    "manufacturer_name": [
     "Long Grove Pharmaceuticals, LLC"
    ],
    "product_ndc": [
     "81298-7620"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM BICARBONATE"
    ],
    "rxcui": [
     "1868486"
    ],
    "spl_id": [
     "1a255946-a137-4e13-8203-65dd80b34872"
    ],
    "spl_set_id": [
     "a26d709b-b294-4b02-9a88-7e840f099a33"
    ],
    "package_ndc": [
     "81298-7620-1",
     "81298-7620-3"
    ],
    "unii": [
     "8MDF5V39QO"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 81298-7620-3)",
   "company_name": "Long Grove Pharmaceuticals LLC",
   "status": "Current"
  },
  {
   "discontinued_date": "11/07/2025",
   "update_type": "New",
   "initial_posting_date": "11/07/2025",
   "package_ndc": "0409-5534-14",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "11/07/2025",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 0409-5534-14)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/01/2017",
   "package_ndc": "0409-6625-35",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "ANDA202432"
    ],
    "brand_name": [
     "SODIUM BICARBONATE"
    ],
    "generic_name": [
     "SODIUM BICARBONATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-6625"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM BICARBONATE"
    ],
    "rxcui": [
     "1868486"
    ],
    "spl_id": [
     "dcc55d90-d55e-4e1a-9e48-5703cbc74a52",
     "c39c0ef6-4140-4c6c-91c4-e43d67872b05"
    ],
    "spl_set_id": [
     "8664c7ce-707b-4c6c-9ce4-7160b5f877f8",
     "084f5572-8c1f-4802-b179-ca0cc838fc68"
    ],
    "package_ndc": [
     "0409-6625-30",
     "0409-6625-35",
     "0409-6625-22",
     "0409-6625-14"
    ],
    "unii": [
     "8MDF5V39QO"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-35)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/01/2017",
   "package_ndc": "0409-6625-14",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202432"
    ],
    "brand_name": [
     "SODIUM BICARBONATE"
    ],
    "generic_name": [
     "SODIUM BICARBONATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-6625"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM BICARBONATE"
    ],
    "rxcui": [
     "1868486"
    ],
    "spl_id": [
     "dcc55d90-d55e-4e1a-9e48-5703cbc74a52",
     "c39c0ef6-4140-4c6c-91c4-e43d67872b05"
    ],
    "spl_set_id": [
     "8664c7ce-707b-4c6c-9ce4-7160b5f877f8",
     "084f5572-8c1f-4802-b179-ca0cc838fc68"
    ],
    "package_ndc": [
     "0409-6625-30",
     "0409-6625-35",
     "0409-6625-22",
     "0409-6625-14"
    ],
    "unii": [
     "8MDF5V39QO"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/24/2017",
   "package_ndc": "63323-089-50",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA206688"
    ],
    "brand_name": [
     "SODIUM BICARBONATE"
    ],
    "generic_name": [
     "SODIUM BICARBONATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-089",
     "63323-083"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM BICARBONATE"
    ],
    "rxcui": [
     "1868469",
     "1868486"
    ],
    "spl_id": [
     "9def795c-abcf-483c-8b1d-e4374666efb2"
    ],
    "spl_set_id": [
     "0ab55004-bb63-436d-ad77-cd3796905370"
    ],
    "package_ndc": [
     "63323-083-03",
     "63323-083-05",
     "63323-089-25",
     "63323-089-50"
    ],
    "unii": [
     "8MDF5V39QO"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "07/24/2017",
   "package_ndc": "63323-083-05",
   "generic_name": "Sodium Bicarbonate Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory.",
   "openfda": {
    "application_number": [
     "ANDA206688"
    ],
    "brand_name": [
     "SODIUM BICARBONATE"
    ],
    "generic_name": [
     "SODIUM BICARBONATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-083",
     "63323-089"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "SODIUM BICARBONATE"
    ],
    "rxcui": [
     "1868469",
     "1868486"
    ],
    "spl_id": [
     "9def795c-abcf-483c-8b1d-e4374666efb2"
    ],
    "spl_set_id": [
     "0ab55004-bb63-436d-ad77-cd3796905370"
    ],
    "package_ndc": [
     "63323-083-03",
     "63323-083-05",
     "63323-089-25",
     "63323-089-50"
    ],
    "unii": [
     "8MDF5V39QO"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  }
 ]
}